Can LLMs Generate Diverse Molecules? Towards Alignment with Structural Diversity
Recent advancements in large language models (LLMs) have demonstrated impressive performance in molecular generation, which offers potential to accelerate drug discovery. However, the current LLMs overlook a critical requirement for drug discovery: proposing a diverse set of molecules. This diversity is essential for improving the chances of finding a viable drug, as it provides alternative molecules that may succeed where others fail in real-world validations. Nevertheless, the LLMs often output structurally similar molecules. While decoding schemes like diverse beam search may enhance textual diversity, this often does not align with molecular structural diversity. In response, we propose a new method for fine-tuning molecular generative LLMs to autoregressively generate a set of structurally diverse molecules, where each molecule is generated by conditioning on the previously generated molecules. Our approach consists of two stages: (1) supervised fine-tuning to adapt LLMs to autoregressively generate molecules in a sequence and (2) reinforcement learning to maximize structural diversity within the generated molecules. Our experiments show that the proposed approach enables LLMs to generate diverse molecules better than existing approaches for diverse sequence generation.
Code (0)
등록된 구현이 없습니다.
Tasks
DiversityDrug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
MolDeTox: Evaluating Language Model's Stepwise Fragment Editing for Molecular Detoxification
Large Language Models (LLMs) and Vision Language Models (VLMs) have recently shown promising capabilities in various scientific domain. In particular, these advances have opened new opportunities in drug discovery, where…
Drug DiscoveryDo LLMs Truly Generalize in the Molecular Domain? A Perturbation-Based Analysis
Large Language Models (LLMs) have recently shown promise in molecular discovery, yet a gap remains between their probabilistic nature over discrete sequential tokens and the rigid topological constraints of chemical spac…
MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design
Structure-based drug design (SBDD), which maps target proteins to candidate molecular ligands, is a fundamental task in drug discovery. Effectively aligning protein structural representations with molecular representatio…
Drug DiscoveryDiversity-Aware Reinforcement Learning for de novo Drug Design
Fine-tuning a pre-trained generative model has demonstrated good performance in generating promising drug molecules. The fine-tuning task is often formulated as a reinforcement learning problem, where previous methods ef…
DiversityDrug Designreinforcement-learningReinforcement LearningRepurformer: Transformers for Repurposing-Aware Molecule Generation
Generating as diverse molecules as possible with desired properties is crucial for drug discovery research, which invokes many approaches based on deep generative models today. Despite recent advancements in these models…
DiversityDrug Discovery